NASDAQ
According to Zyberno, Kewaunee Scientific Corporation (KEQU) shows a Value Trap signal — GOOD BUSINESS (65/100) with an apparent Margin of Safety of +67.8%, but a Brina Gap of +1.2% reveals the current price still assumes faster growth than the business can deliver.
According to Zyberno's DCF model, Kewaunee Scientific Corporation (KEQU) trades at $37.80 against an estimated intrinsic value per share of $117.40 — a +67.8% Margin of Safety based on Owner Earnings of $14.70M TTM, projected at 13.3% growth for 10 years with a 2.5% terminal growth rate. The Brina Gap of +1.2% strengthens the case: based on the company's ROIC (14.9%) and reinvestment rate (-18.1%), the business can fundamentally grow at -2.7% — but the current enterprise value implies the market expects -3.9%. This places KEQU in the Value Trap quadrant of the Brina Matrix — a value-trap signal where the apparent discount is undermined by overpriced growth expectations. Zyberno's model translates this into a 5-year expected return of 43.1% annually.
Over the trailing twelve months, KEQU generated $14.70M in Owner Earnings. Capital was deployed as follows: $3.94M invested in capital expenditures. Reinvestment rate: -18.1%. Owner Earnings have grown at 13.3% annually over the trailing five years using log-linear regression.